pharma · Persistent Corneal Epithelial Defect (PCED) · Recent onset Type 1 Diabetes
Doppel Farmaceutici
Dompe' Farmaceutici S.p.A.
Doppel Farmaceutici trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.
Via Martiri delle Foibe 1, Cortemaggiore (PC), Emilia-Romagna 29016, IT, napoli HQ
1994 Founded
393 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Via Martiri delle Foibe 1, Cortemaggiore (PC), Emilia-Romagna 29016, IT, napoli
- Founded
- 1994
- Employees
- 393
- Programs
- 11
- Drugs
- 14
- Patents
- 0
Doppel Farmaceutici clinical trials
Registry index of 11 ClinicalTrials.gov studies linked to Doppel Farmaceutici programs — each row shows trial ID, program name, phase, status, and indication.
Doppel Farmaceutici trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Doppel Farmaceutici.
-
LDX-HV-101 — Phase 1
Clinical update -
DF2755A-HV-101 — Phase 1
Clinical update -
NGF0123 — Phase 2
Clinical update -
ICY0123 — Phase 2
Clinical update -
NGF-PCED-301 — Phase 3
Clinical update -
NGF-CP-201 — Phase 2
Clinical update -
ICY-AKC-301 — Phase 3
Clinical update -
TACHIPIRINA compresse for Chronic low back pain — Phase 2
Clinical update